Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| VERA | 8-K | bullish | 8/10 | Vera Therapeutics announced that TRUTAKNA (atacicept-vymj) met all prespecified endpoints in the final efficacy analysis | Sep 15, 2026 |
| RKLB | 8-K | mixed | 7/10 | Rocket Lab announced it has fully financed its pending $1.944 billion acquisition of Iridium Communications by completin | Sep 15, 2026 |
| BLSM | 8-K | neutral | 3/10 | BlossomHill Therapeutics filed an 8-K with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (exhibits), but the docume | Sep 15, 2026 |
| AXP | 8-K | neutral | 3/10 | American Express issued a Regulation FD disclosure (Item 7.01) regarding its 3.835% Fixed-to-Floating Rate Notes due Jun | Sep 15, 2026 |
| ZEOX | 8-K | neutral | 2/10 | ZEO ScientifiX filed an 8-K announcing its planned expansion into Georgia and Tennessee following the enactment of new s | Sep 15, 2026 |
| QXL | 8-K | bullish | 6/10 | Quantum X Labs appointed Yossi Cohen, former Mossad Director and current SoftBank strategic advisor, as President of its | Sep 15, 2026 |
| CWK | 8-K | neutral | 2/10 | Cushman & Wakefield disclosed the resignation of Chief Accounting Officer Laurida Sayed, effective September 25, 2026, t | Sep 15, 2026 |
| ASPN | 8-K | mixed | 6/10 | Aspen Aerogels filed an 8-K furnishing an investor presentation on September 15, 2026. The presentation highlights a ret | Sep 15, 2026 |
| CTNT | 8-K | neutral | 4/10 | Cheetah Net Supply Chain Service Inc. (CTNT) entered into a definitive agreement to acquire 100% of JoyPak Supply LLC, a | Sep 15, 2026 |
| NTRP | 8-K | neutral | 3/10 | NextTrip announced via press release that its JOURNY TV platform will premiere its first original series, 'I DO: In Dest | Sep 15, 2026 |
| LBRX | 8-K | neutral | 3/10 | LB Pharmaceuticals Inc. filed an 8-K covering Item 5.02 (officer/director departure or appointment), Item 7.01 (Regulati | Sep 15, 2026 |
| RBA | 8-K | neutral | 3/10 | RB Global Inc. filed an 8-K with Items 8.01 and 9.01, but the document content was unavailable, so no specific event det | Sep 15, 2026 |
| INTZ | 8-K | neutral | 3/10 | Intrusion Inc. filed an 8-K under Item 5.02 regarding a departure or appointment of a director or officer. No financial | Sep 15, 2026 |
| CTVA | 8-K | neutral | 3/10 | Corteva filed an 8-K with Regulation FD disclosure (Item 7.01) and other events (Item 8.01), accompanied by exhibits (It | Sep 15, 2026 |
| LPBB | 425, 8-K | neutral | 4/10 | Launch Two Acquisition Corp. (LPBB) publicly filed its S-4 registration statement with the SEC on September 11, 2026, fo | Sep 15, 2026 |
| INOD | 8-K | neutral | 3/10 | Innodata appointed Admiral Michael S. Rogers, former NSA Director and Commander of U.S. Cyber Command, to its Board of D | Sep 15, 2026 |
| SAFX | 8-K | bearish | 8/10 | XCF Global entered into an at-the-market (ATM) sales agreement with Roth Capital and H.C. Wainwright to sell up to $100M | Sep 15, 2026 |
| CTEV | 8-K | neutral | 3/10 | Claritev appointed Ben Letham, a Meta research scientist and AI expert, to its Board of Directors to fill a vacancy. The | Sep 15, 2026 |
| RTB | 8-K | neutral | 5/10 | RTB Digital filed an 8-K announcing a shareholder call on September 17, 2026, where CEO James Heckman will detail a sign | Sep 15, 2026 |
| COYA | 8-K | neutral | 4/10 | Coya Therapeutics announced that the 100th patient has been enrolled in its Phase 2/3 ALSTARS trial (COYA 302 for ALS), | Sep 15, 2026 |
| OTIS | 8-K | neutral | 3/10 | Otis announced that CEO Judy Marks will retire upon appointment of her successor, expected in H1 2027, with a transition | Sep 15, 2026 |
| JAZZ | 8-K | bullish | 6/10 | Jazz Pharmaceuticals completed the acquisition of Actio Biosciences for $820 million upfront, adding ABS-1230, a clinica | Sep 15, 2026 |
| BAND | 8-K | neutral | 4/10 | Bandwidth Inc. filed an 8-K furnishing an investor presentation for Q3 2026 conferences. The presentation reiterates pri | Sep 15, 2026 |
| FBNC | 8-K | neutral | 3/10 | First Bancorp (FBNC) filed a Form 8-K with Items 8.01 and 9.01, indicating an 'Other Events' disclosure. The document co | Sep 15, 2026 |
| AEMD | 8-K | neutral | 2/10 | Aethlon Medical amended the employment agreements of its CEO/CFO and CMO to convert severance and COBRA payments from in | Sep 15, 2026 |
| TDAY | 8-K | neutral | 2/10 | USA TODAY Co. appointed Tim Allen, CEO of Babbel, as an independent director, expanding the board to nine members. Allen | Sep 15, 2026 |
| AGNT | 8-K | neutral | 2/10 | AGNT, Inc. filed an 8-K solely to report an Item 8.01 Other Events item. The filing contains no financial results, no ma | Sep 15, 2026 |
| TG | 8-K | neutral | 3/10 | Tredegar Corp filed an 8-K covering Item 5.02 (officer/director change), Item 7.01 (Regulation FD disclosure), and Item | Sep 15, 2026 |
| INV | 8-K | bullish | 5/10 | Senior management and directors of Innventure voluntarily forfeited 435,168 shares of common stock that were previously | Sep 15, 2026 |
| OBK | 8-K | bearish | 7/10 | Origin Bancorp, Inc. filed an 8-K with Items 3.01 (Delisting Notice), 7.01 (Regulation FD Disclosure), and 9.01 (Financi | Sep 15, 2026 |